Utama › Leukemia Mieloid Akut › Vermont › Burlington
Kajian klinikal Leukemia Mieloid Akut di Burlington, VT
7 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Burlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Mengambil pesertaFasa 3
- University of Vermont and State Agricultural College, Burlington
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Mengambil pesertaFasa 3
- University of Vermont Medical Center, Burlington
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- University of Vermont, Burlington
Kajian Leukemia Mieloid Akut di bandar lain
- Houston, TX85 kajian
- New York City, NY51 kajian
- Boston, MA44 kajian
- Baldwin Park, CA40 kajian
- Seattle, WA40 kajian
- Columbus, OH35 kajian
- Philadelphia, PA34 kajian
- Durham, NC33 kajian
- Atlanta, GA30 kajian
- Tampa, FL29 kajian
- Chicago, IL26 kajian
- Portland, OR25 kajian
Kajian lain di Burlington
- Kegagalan Jantung8 kajian
- Kanser (semua jenis)6 kajian
- COPD5 kajian
- Kanser Payudara5 kajian
- Penyakit Parkinson4 kajian
- Kanser Paru-paru Bukan Sel Kecil4 kajian
- Kanser Prostat4 kajian
- Fibrosis Kistik4 kajian
- Penyakit Paru-paru4 kajian
- Leukemia4 kajian
- Penyakit Kardiovaskular4 kajian
- Kanser Metastatik4 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.